Apotek i Kristiansand: Industrioversikt og Utsikt

Pharmacies in Kristiansand form a stable and growing sector with 31 registered companies across the municipality. The industry shows consistent revenue growth, with sales reaching NOK 893.6M in 2025, driven by strong performance in Kristiansand city center and surrounding areas. Key metrics include an average EBITDA margin of 6-7% and gross margins exceeding 14,000% in some locations. The sector is dominated by AS-structured companies, with 27 of 31 firms operating under this legal form. Notable players include Apotek 1 Sørlandssenteret and Vitusapotek Elefanten, which report operating incomes exceeding NOK 50M annually.

The pharmacy sector in Kristiansand has shown mixed but generally positive economic trends:

• Sales Growth: Sales fluctuated significantly between 2016-2017 (-48.3%) but rebounded strongly in 2018 (+147.9%) and maintained steady growth through 2025 (NOK 893.6M, +13.0% YoY)
• Employee Trends: Employment grew from 256 in 2016 to 350 in 2026, with notable increases in 2023 (+9.4%) and 2026 (+9.0%)
• Profitability: Average EBITDA margin of 6.5% and gross margins exceeding 14,000% in some locations
• Debt Levels: Total debt across the sector reached NOK 199.8M in 2026, with average debt per company at NOK 6.4M
• Equity: Total equity stood at NOK 39.7M in 2026, with an average of NOK 1.3M per company

The pharmacy sector in Kristiansand includes 31 registered companies, with 16 specifically listed in the provided data. Key characteristics include:

Company Distribution:

• 14 companies operating under the AS legal form
• 2 companies with zero reported sales (Apotek 1 Grim and Sør Apotek As)
• 3 companies with zero operating income (Apotek 1 Aquarama, Apotek 1 Lund, and Apotek 1 Fagerholt)

Notable Companies:

Organisation Form Statistics:

• AS-structured companies dominate with 27 firms (87% of total)
• Average employees per AS company: 13
• Average sales per AS company: NOK 26.6M

Pharmacy activity in Kristiansand is distributed across multiple locations:

Kristiansand (City Center):

• 23 companies
• 301 employees
• NOK 558.8M sales revenue
• EBITDA of NOK 37.9M
• Leading locations: Barstølveien, Østre Strandgate, and Skippergata

Søgne:

• 2 companies
• 31 employees
• NOK 38.7M sales revenue
• EBITDA of NOK 2.8M

Nodeland:

• 1 company
• 11 employees
• NOK 35.5M sales revenue
• EBITDA of NOK 2.2M

Hamresanden:

• 1 company
• 6 employees
• NOK 11.8M sales revenue
• EBITDA of NOK 734.0K

The city center dominates with 75% of all pharmacy activity, while smaller towns show potential for niche specialization.

The pharmacy sector in Kristiansand shows strong resilience:

• Bankruptcy Statistics: No bankruptcies reported in the sector between 2016-2026
• Stability: All 16 listed companies are currently operational
• Performance Variance: While most companies report positive EBITDA, three companies (Apotek 1 Aquarama, Apotek 1 Lund, and Apotek 1 Fagerholt) show zero financial activity
• Debt Management: Average debt per company is NOK 6.4M, with total sector debt at NOK 199.8M
• Equity Position: Total equity across the sector reached NOK 39.7M in 2026, with an average of NOK 1.3M per company

The sector's stability is reinforced by its high gross margins (14,000% average) and consistent revenue growth despite fluctuations in individual company performance.

For founders considering entering the pharmacy sector in Kristiansand, the data suggests:

• Positive Growth Trends: Sales have increased by 13.0% YoY in 2025, with consistent growth since 2018
• Profitability Potential: Average EBITDA margin of 6.5% and gross margins exceeding 14,000% indicate strong profitability
• Market Saturation: With 31 companies in the municipality, new entrants should focus on niche specialization or underserved areas like Nodeland and Hamresanden
• Operational Efficiency: Leading companies achieve NOK 2.9M operating income per employee, suggesting room for improvement in less efficient firms
• Stability: No bankruptcies reported in the sector between 2016-2026

SmartGrunder can help identify optimal locations within Kristiansand for new pharmacy ventures, particularly in areas with lower competition and higher growth potential.

When compared to the broader håndverk (craftsmanship) industry in Kristiansand, the pharmacy sector shows distinct characteristics:

• Company Count: Pharmacy has 31 companies vs. 32 in the broader håndverk category
• Sales Trends: Both sectors show similar growth patterns, with sales increasing from NOK 454.7M in 2016 to NOK 893.6M in 2025
• Employee Growth: Both sectors show similar employment trends, increasing from 256 in 2016 to 350 in 2026
• Profitability: Pharmacy companies achieve slightly higher EBITDA margins (6.5% vs. 6.0% in håndverk)

Peer Comparison:

While the broader håndverk category includes companies like Erøy Holding As with negative EBITDA, the pharmacy sector maintains consistently positive financial performance across all listed companies.

The pharmacy sector in Kristiansand presents a compelling opportunity for new entrants, with stable growth, strong profitability, and no bankruptcies reported in the sector. While the market is already saturated with 31 companies, there are opportunities in niche areas like Nodeland and Hamresanden. Founders should focus on operational efficiency, leveraging the sector's high gross margins (14,000% average) and consistent revenue growth. SmartGrunder can assist in identifying optimal locations and analyzing market needs for new pharmacy ventures in Kristiansand.